<VariationArchive VariationID="402534" VariationName="NM_030787.4(CFHR5):c.486dup (p.Glu163fs)" VariationType="Duplication" Accession="VCV000402534" Version="32" RecordType="classified" NumberOfSubmissions="10" NumberOfSubmitters="10" DateLastUpdated="2024-07-07" DateCreated="2017-04-10" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="390510" VariationID="402534">
      <GeneList>
        <Gene Symbol="CFHR5" FullName="complement factor H related 5" GeneID="81494" HGNC_ID="HGNC:24668" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1q31.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="196975034" stop="197009678" display_start="196975034" display_stop="197009678" Strand="+" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NW_025791754.1" start="740149" stop="774808" display_start="740149" display_stop="774808" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="196946666" stop="196978803" display_start="196946666" display_stop="196978803" Strand="+" />
          </Location>
          <OMIM>608593</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_030787.4(CFHR5):c.486dup (p.Glu163fs)</Name>
      <CanonicalSPDI>NC_000001.11:196994128:AAAAAAA:AAAAAAAA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>1q31.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="196994128" stop="196994129" display_start="196994128" display_stop="196994129" variantLength="1" positionVCF="196994128" referenceAlleleVCF="C" alternateAlleleVCF="CA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="196963258" stop="196963259" display_start="196963258" display_stop="196963259" variantLength="1" positionVCF="196963258" referenceAlleleVCF="C" alternateAlleleVCF="CA" />
      </Location>
      <OtherNameList>
        <Name>p.Glu163ArgfsX35</Name>
        <Name>p.Glu163Argfs*35</Name>
      </OtherNameList>
      <ProteinChange>E163fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.196963265dup" Assembly="GRCh37">
            <Expression>NC_000001.10:g.196963265dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.196994135dup" Assembly="GRCh38">
            <Expression>NC_000001.11:g.196994135dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_016365.1" sequenceAccession="NG_016365" sequenceVersion="1" change="g.21599dup">
            <Expression>NG_016365.1:g.21599dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_030787.4" sequenceAccession="NM_030787" sequenceVersion="4" change="c.486dup" MANESelect="true">
            <Expression>NM_030787.4:c.486dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_110414.1" sequenceAccession="NP_110414" sequenceVersion="1" change="p.Glu163fs">
            <Expression>NP_110414.1:p.Glu163fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_227" sequenceAccession="LRG_227">
            <Expression>LRG_227:g.21599dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_227t1" sequenceAccession="LRG_227t1">
            <Expression>LRG_227t1:c.486dup</Expression>
          </NucleotideExpression>
          <ProteinExpression change="p.Glu163fs">
            <Expression>LRG_227p1:p.Glu163fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_030787.3" sequenceAccession="NM_030787" sequenceVersion="3" change="c.486dupA">
            <Expression>NM_030787.3:c.486dupA</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA1307761" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="608593.0002" DB="OMIM" />
        <XRef Type="rs" ID="565457964" DB="dbSNP" />
      </XRefList>
      <GlobalMinorAlleleFrequency Value="0.00080" Source="1000 Genomes Project" MinorAllele="AAAAAAAA" />
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_030787.4(CFHR5):c.486dup (p.Glu163fs) AND CFHR5 deficiency" Accession="RCV000030802" Version="19">
        <ClassifiedConditionList TraitSetID="8912">
          <ClassifiedCondition DB="MedGen" ID="C3553720">CFHR5 deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, conflicting classifications</ReviewStatus>
            <Description DateLastEvaluated="2021-08-06" SubmissionCount="3">Conflicting interpretations of pathogenicity</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_030787.4(CFHR5):c.486dup (p.Glu163fs) AND not specified" Accession="RCV000455834" Version="8">
        <ClassifiedConditionList TraitSetID="9590">
          <ClassifiedCondition DB="MedGen" ID="CN169374">not specified</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2022-01-04" SubmissionCount="2">Uncertain significance</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_030787.4(CFHR5):c.486dup (p.Glu163fs) AND not provided" Accession="RCV000767072" Version="16">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, conflicting classifications</ReviewStatus>
            <Description DateLastEvaluated="2024-01-19" SubmissionCount="3">Conflicting interpretations of pathogenicity</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_030787.4(CFHR5):c.486dup (p.Glu163fs) AND Chronic kidney disease" Accession="RCV001171343" Version="2">
        <ClassifiedConditionList TraitSetID="24482">
          <ClassifiedCondition DB="MedGen" ID="C1561643">Chronic kidney disease</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-05-28" SubmissionCount="1">Uncertain significance</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_030787.4(CFHR5):c.486dup (p.Glu163fs) AND C3 glomerulonephritis" Accession="RCV004576953" Version="1">
        <ClassifiedConditionList TraitSetID="79371">
          <ClassifiedCondition DB="MedGen" ID="C4055342">C3 glomerulonephritis</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2012-07-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-01-19" NumberOfSubmissions="10" NumberOfSubmitters="10" DateCreated="2017-04-10" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, conflicting classifications</ReviewStatus>
        <Description>Conflicting classifications of pathogenicity</Description>
        <Explanation DataSource="ClinVar" Type="public">Uncertain significance(7); Benign(1); Likely benign(1)</Explanation>
        <Citation Type="general">
          <ID Source="PubMed">17000000</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22503529</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22527104</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25260719</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28054583</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28750028</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30295827</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31664448</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32723786</ID>
        </Citation>
        <Comment DataSource="ClinVar" Type="public">Uncertain significance(7); Benign(1); Likely benign(1)</Comment>
        <DescriptionHistory Dated="2019-12-15">
          <Description>Uncertain significance</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2018-10-29">
          <Description>Uncertain significance</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2018-10-29">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9590" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16789" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">AllHighlyPenetrant</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not specified</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not specified' was created for use in ClinVar so that submitters can convey the concept that a variant is benign, likely benign, or of uncertain significance for an unspecified set of disorders.  This usage was introduced in 2014 to replace AllHighlyPenetrant.</Attribute>
              </AttributeSet>
              <XRef ID="CN169374" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="8912" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17392" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">CFHR5 deficiency</ElementValue>
              </Name>
              <XRef ID="C3553720" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="24482" Type="Finding" ContributesToAggregateClassification="true">
            <Trait ID="30502" Type="Finding">
              <Name>
                <ElementValue Type="Preferred">Chronic kidney disease</ElementValue>
                <XRef ID="HP:0012622" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0005300" DB="MONDO" />
              </Name>
              <Citation Type="practice guideline" Abbrev="NICE, 2023">
                <URL>https://www.nice.org.uk/guidance/cg181</URL>
                <CitationText>UK NICE Guidance, Clinical Guideline CG181, Cardiovascular disease: risk assessment and reduction, including lipid modification, 2023</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2021">
                <URL>https://www.nice.org.uk/guidance/ng203</URL>
                <CitationText>UK NICE Guideline NG203, Chronic kidney disease: assessment and management, 2021</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2023">
                <URL>https://www.nice.org.uk/guidance/ng238</URL>
                <CitationText>UK NICE Guideline NG238, Cardiovascular disease: risk assessment and reduction, including lipid modification, 2023</CitationText>
              </Citation>
              <XRef ID="C1561643" DB="MedGen" />
              <XRef ID="MONDO:0005300" DB="MONDO" />
              <XRef Type="primary" ID="HP:0012622" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0000106" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0001918" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0008671" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="79371" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="18747" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">C3 glomerulonephritis</ElementValue>
                <XRef ID="MONDO:0013892" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">C3 GLOMERULOPATHY 3</ElementValue>
                <XRef Type="MIM" ID="614809" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608593.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608593.0002" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">C3GN</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">C3G</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16487" />
                <XRef ID="16487" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="329931" DB="Orphanet" />
              <XRef ID="C4055342" DB="MedGen" />
              <XRef ID="MONDO:0013892" DB="MONDO" />
              <XRef Type="MIM" ID="614809" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1049730" SubmissionDate="2019-03-21" DateLastUpdated="2018-04-09" DateCreated="2017-04-10">
        <ClinVarSubmissionID localKey="67716204|not specified" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000538667" DateUpdated="2018-04-09" DateCreated="2017-04-10" Type="SCV" Version="2" SubmitterName="Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine" OrgID="21766" OrganizationCategory="laboratory" OrgAbbreviation="LMM" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-10-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
          <Citation>
            <ID Source="PubMed">17000000</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25260719</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22503529</ID>
          </Citation>
          <Comment>Variant classified as Uncertain Significance - Favor Benign. The p.Glu163ArgfsX3 5 variant in CFHR5 (also reported as p.Glu163Arg and p.Asn197Stop) has been prev iously reported in at least two heterozygous individuals with CFHR5-deficiency a nd complement-mediated kidney diseases, as well as at least three asymptomatic i ndividuals (1 control and 2 family members of 1 of the heterozygotes; Monteferra nte 2007, Vernon 2012, and Figueres 2014). This variant has also been reported i n ClinVar (Variation ID#402534). It has been identified in 0.31% (395/126014) Eu ropean chromosomes by the Genome Aggregation Database (http://gnomad.broadinstit ute.org; rs565457964). This variant is predicted to cause a frameshift, which al ters the protein?s amino acid sequence beginning at position 163 and leads to a premature termination codon 35 amino acids downstream. This alteration is then p redicted to lead to a truncated or absent protein. In summary, while the clinica l significance of the p.Glu163ArgfsX35 variant is uncertain, these data suggest that it is more likely to be benign.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LMM Criteria</Attribute>
          <Citation>
            <ID Source="PubMed">24033266</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>not provided</AffectedStatus>
              <FamilyData NumFamiliesWithVariant="1" />
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="2" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CFHR5" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_030787.3:EXON 4</GeneLocation>
          </Location>
          <OtherNameList>
            <Name>NM_030787.3:c.486dupA</Name>
            <Name>p.Glu163ArgfsX35</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000001.10:g.196963265_196963266insA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not specified</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5348977</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2241288" SubmissionDate="2019-10-22" DateLastUpdated="2020-01-11" DateCreated="2020-01-11">
        <ClinVarSubmissionID localKey="NC_000001.10:g.196963258_196963259insA|OMIM:614809" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001135489" DateUpdated="2020-01-11" DateCreated="2020-01-11" Type="SCV" Version="1" SubmitterName="Mendelics" OrgID="500035" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-05-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Benign</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Mendelics Assertion Criteria 2017</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/chhjzatu/mendelics_assertion_criteria_2017.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CFHR5" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000001.10:g.196963258_196963259insA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="614809" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>MENDELICS_CLINVAR_020</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2561646" SubmissionDate="2020-05-28" DateLastUpdated="2020-05-31" DateCreated="2020-05-31">
        <ClinVarSubmissionID localKey="NM_030787.4:c.480dupA|HPO:HP:0012622" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV001328290" DateUpdated="2020-05-31" DateCreated="2020-05-31" Type="SCV" Version="1" SubmitterName="Cavalleri Lab, Royal College of Surgeons in Ireland" OrgID="506791" OrganizationCategory="laboratory" OrgAbbreviation="CAV-LAB" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-05-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
          <Comment>PVS1, BS1</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CFHR5" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_030787.4:exon4</GeneLocation>
          </Location>
          <OtherNameList>
            <Name>p.P160fs</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_030787.4:c.480dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Finding">
          <Trait Type="Finding">
            <XRef DB="HP" ID="HP:0012622" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB7512178</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="88801" SubmissionDate="2021-03-30" DateLastUpdated="2021-04-03" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="608593.0002_C3 GLOMERULOPATHY 3" title="CFHR5, 1-BP INS, 485A_C3 GLOMERULOPATHY 3" />
        <ClinVarAccession Accession="SCV000053471" DateUpdated="2021-04-03" DateCreated="2013-04-04" Type="SCV" Version="4" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2012-07-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a girl with C3 glomerulopathy-3 (C3G3; 614809) and persistent renal disease following a streptococcal infection, Vernon et al. (2012) identified a heterozygous 1-bp insertion (485dupA) in exon 4 of the CFHR5 gene, resulting in a frameshift and premature termination (Glu163ArgfsTer34). The mutation was not found in 198 controls in this study, but was present in her unaffected mother and sister. The patient presented at age 7 years with dark-colored proteinuria after a 10-day history of fever and sore throat. After treatment for the infection, she had persistent hematuria and proteinuria. Nine months later, kidney biopsy showed mesangial hypercellularity, segmental endocapillary hypercellularity, and segmental capillary wall double contours. There was mesangial and capillary deposition of C3 (120700), C9 (120940), and CFHR5. Electron microscopy showed thickening of the glomerular basement membranes, intramembranous electron-dense deposits, and subendothelial and subepithelial deposits. Serum CFHR5 was decreased to 37.3% of control values. Treatment with an angiotensin receptor (see 106165) blocker resulted in improved kidney function. The presence of the mutation in her unaffected mother and sister suggested that it is not sufficient to cause disease, but likely acts as a susceptibility factor for the development of glomerulonephritis.</Attribute>
              <Citation>
                <CitationText>Vernon, K. A., Goicoechea de Jorge, E., Hall, A. E., Fremeaux-Bacchi, V., Aitman, T. J., Cook, H. T., Hangartner, R., Koziell, A., Pickering, M. C. Acute presentation and persistent glomerulonephritis following streptococcal infection in a patient with heterozygous complement factor H-related protein 5 deficiency. Am. J. Kidney Dis. 60: 121-125, 2012.</CitationText>
              </Citation>
              <XRef DB="OMIM" ID="614809" Type="MIM" />
              <XRef DB="OMIM" ID="120700" Type="MIM" />
              <XRef DB="OMIM" ID="120940" Type="MIM" />
              <XRef DB="OMIM" ID="106165" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CFHR5" />
          </GeneList>
          <Name>CFHR5, 1-BP INS, 485A</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP INS, 485A</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="608593.0002" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">C3 GLOMERULOPATHY 3</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1103949" SubmissionDate="2021-09-25" DateLastUpdated="2019-04-17" DateCreated="2017-04-10">
        <ClinVarSubmissionID localKey="GDXSV:156156" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV000568842" DateUpdated="2019-04-17" DateCreated="2017-04-10" Type="SCV" Version="4" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" OrgAbbreviation="GDX" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-07-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
          <Comment>Identified in individuals with renal disease, however, it has also been reported in clinically asymptomatic individuals (Monteferrante et al., 2007; Vernon et al., 2012; Figueres et al., 2014; Schapiro et al., 2019); Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is not a known mechanism of disease; Observed in one homozygous clinically unaffected adult relative of an individual referred for genetic testing at GeneDx; Also known as c.485dupA and Asn1975Stop using alternate nomenclature; This variant is associated with the following publications: (PMID: 30295827, 31664448, 22503529, 25260719, 17000000, 31980526)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CFHR5" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:759505</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_030787.3:c.486dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_51_20210925044204</SubmissionName>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3878534" SubmissionDate="2021-10-04" DateLastUpdated="2021-10-30" DateCreated="2021-10-30">
        <ClinVarSubmissionID localKey="NM_030787.3:c.486dupA|OMIM:614809" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001984583" DateUpdated="2021-10-30" DateCreated="2021-10-30" Type="SCV" Version="1" SubmitterName="Al Jalila Childrenâ€™s Genomics Center, Al Jalila Childrens Speciality Hospital" OrgID="507199" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-03-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CFHR5" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_030787.3:c.486dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="614809" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10465084</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4065547" SubmissionDate="2022-02-09" DateLastUpdated="2022-02-12" DateCreated="2022-02-12">
        <ClinVarSubmissionID localKey="NM_030787.3:c.486dupA|MedGen:CN169374" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002074527" DateUpdated="2022-02-12" DateCreated="2022-02-12" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-01-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
          <Citation>
            <ID Source="PubMed">17000000</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22527104</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28750028</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31664448</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">32723786</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25260719</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30295827</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28054583</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22503529</ID>
          </Citation>
          <Comment>Variant summary: CFHR5 c.486dupA (p.Glu163ArgfsX35) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant allele was found at a frequency of 0.002 in 251100 control chromosomes, predominantly at a frequency of 0.0031 within the Non-Finnish European subpopulation in the gnomAD database. The observed variant frequency within Non-Finnish European control individuals in the gnomAD database is approximately 50 fold of the estimated maximal expected allele frequency for a pathogenic variant in CFHR5 causing CFHR5 Deficiency phenotype (6.3e-05), strongly suggesting that the variant is a benign polymorphism found primarily in populations of Non-Finnish European origin. c.486dupA has been reported in the literature in individuals affected with CFHR5 Deficiency as well as in at least three healthy individuals (Monteferrante_2006, Vernon_2012, Figueres_2014, Benson_2020). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Eight ClinVar submitters (evaluation after 2014) cite the variant as uncertain significance (n=5), likely benign (n=1), benign (n=1) and pathogenic (n=1). Based on the evidence outlined above, the variant was classified as uncertain significance.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CFHR5" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_030787.3:c.486dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN169374" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11058952</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3376074" SubmissionDate="2023-09-15" DateLastUpdated="2023-09-20" DateCreated="2021-06-15">
        <ClinVarSubmissionID localKey="NM_030787.3:c.486dup|Not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001715641" DateUpdated="2023-09-20" DateCreated="2021-06-15" Type="SCV" Version="2" SubmitterName="Mayo Clinic Laboratories, Mayo Clinic" OrgID="500068" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-11-30">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CFHR5" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_030787.3:exon 4</GeneLocation>
          </Location>
          <OtherNameList>
            <Name>p.Glu163Argfs*35</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_030787.3:c.486dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13844625</SubmissionName>
          <SubmissionName>SUB9741791</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7135945" SubmissionDate="2024-01-26" DateLastUpdated="2024-02-04" DateCreated="2023-03-04">
        <ClinVarSubmissionID localKey="6f24664dfa49c833fdfbaba5977531c7fadcbe73ce6434629271a1f377761f94|OMIM:614809" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003831622" DateUpdated="2024-02-04" DateCreated="2023-03-04" Type="SCV" Version="2" SubmitterName="Revvity Omics, Revvity" OrgID="167595" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-08-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_030787.4:c.486dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="614809" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12922107</SubmissionName>
          <SubmissionName>SUB14173319</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1996828" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2019-12-17">
        <ClinVarSubmissionID localKey="2352530|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001028978" DateUpdated="2024-02-14" DateCreated="2019-12-17" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely benign</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CFHR5" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000001.10:g.196963258_196963259insA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB6897608</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1049730" TraitType="Disease" MappingType="Name" MappingValue="not specified" MappingRef="Preferred">
        <MedGen CUI="CN169374" Name="not specified" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="88801" TraitType="Disease" MappingType="Name" MappingValue="C3 GLOMERULOPATHY 3" MappingRef="Preferred">
        <MedGen CUI="C4055342" Name="C3 glomerulonephritis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3376074" TraitType="Disease" MappingType="Name" MappingValue="Not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1996828" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2241288" TraitType="Disease" MappingType="XRef" MappingValue="614809" MappingRef="OMIM">
        <MedGen CUI="C4055342" Name="C3 glomerulonephritis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2561646" TraitType="Finding" MappingType="XRef" MappingValue="HP:0012622" MappingRef="HP">
        <MedGen CUI="C1561643" Name="Chronic kidney disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3878534" TraitType="Disease" MappingType="XRef" MappingValue="614809" MappingRef="OMIM">
        <MedGen CUI="C4055342" Name="C3 glomerulonephritis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4065547" TraitType="Disease" MappingType="XRef" MappingValue="CN169374" MappingRef="MedGen">
        <MedGen CUI="CN169374" Name="not specified" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1103949" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7135945" TraitType="Disease" MappingType="XRef" MappingValue="614809" MappingRef="OMIM">
        <MedGen CUI="C4055342" Name="C3 glomerulonephritis" />
      </TraitMapping>
    </TraitMappingList>
    <DeletedSCVList>
      <SCV>
        <Accession Version="1" DateDeleted="2021-05-09">SCV001483097</Accession>
        <Description>not specified</Description>
      </SCV>
    </DeletedSCVList>
  </ClassifiedRecord>
</VariationArchive>

